Substances

All active substances (INN) in EU-authorised medicines

1,849 Substances

1-13C-caprylic acid

INN (International Nonproprietary Name)

5-aminolevulinic acid hydrochloride

INN (International Nonproprietary Name)

Substances

1-13C-caprylic acid

5-aminolevulinic acid hydrochloride

1-13C-caprylic acid

5-aminolevulinic acid hydrochloride

6-mercaptopurine monohydrate

A22 Iraq ≥ 6 PD50*

A24 Cruzeiro ≥ 6 PD50*

A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)

abacavir

abacavir (as sulfate)

abaloparatide

abatacept

abemaciclib

abetimus

abicipar pegol

abiraterone acetate

abrocitinib

acalabrutinib

acalabrutinib maleate

A/California/07/2009 (H1N1)pdm09-like strain (A/California/07/2009)

acetylsalicylic acid

aclidinium bromide

acoramidis hydrochloride

adagrasib

adalimumab

A/Darwin/1415/2025 (H3N2)-like strain (A/Tasmania/787/2025, CVR-388)

A/Darwin/1454/2025 (H3N2) - like strain (A/Darwin/1369/2025, MEDI 406666)

A/Darwin/1454/2025 (H3N2)-like strain (A/Michigan/105/2025, IVR-285)

A/Darwin/9/2021 (H3N2) - like strain (A/Norway/16606/2021, MEDI 355293) / A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/1/2020, MEDI 340505) / B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, MEDI 355292) / B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, MEDI 306444)

adefovir dipivoxil

adenovirus-mediated Herpes simplex virus-thymidine kinase gene

adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)

adsorbed hepatitis B surface antigen produced in recombinant yeast cells (Saccharomyces cerevisiae)

aducanumab

afamelanotide

afatinib

aficamten

aflibercept

afoxolaner

agalsidase alfa

agalsidase beta

agomelatine

A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)

alatrofloxacin mesilate

albiglutide

albutrepenonacog alfa

alectinib hydrochloride

alemtuzumab

alendronate sodium trihydrate

alendronic acid

alendronic acid (as sodium trihydrate)

alglucosidase alfa